BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10114004)

  • 21. A comparative evaluation of cimetidine and ranitidine.
    Zimmerman TW; Schenker S
    Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770
    [No Abstract]   [Full Text] [Related]  

  • 22. Actions of cimetidine and ranitidine at some cholinergic sites: implications in toxicology and anesthesia.
    Gwee MC; Cheah LS
    Life Sci; 1986 Aug; 39(5):383-8. PubMed ID: 2874464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study.
    He Y; Chan EW; Man KK; Lau WC; Leung WK; Ho LM; Wong IC
    Drug Saf; 2014 Sep; 37(9):711-21. PubMed ID: 25096957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine H2-receptor antagonists for urticaria.
    Fedorowicz Z; van Zuuren EJ; Hu N
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008596. PubMed ID: 22419335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
    Segal R; Oh T; Ben-Joseph R; Russell WL
    Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
    James OF; Parry-Billings KS
    Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer.
    Silvis SE
    J Clin Gastroenterol; 1985 Dec; 7(6):482-7. PubMed ID: 3910710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis.
    Weinberg DS; Burnham D; Berlin JA
    J Gen Intern Med; 1998 Sep; 13(9):594-9. PubMed ID: 9754514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical use of histamine-2 receptor antagonists.
    Michocki RJ; Richardson JP
    Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuropsychic effects of cimetidine and ranitidine. Apropos of 1 case].
    Ducluzeau R; Vial T; Pobel D; Descotes J
    J Toxicol Clin Exp; 1990; 10(1):37-9. PubMed ID: 2362253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An examination of histamine-2 receptor antagonist use by Medicaid recipients in Wisconsin long-term care facilities.
    Lipowski EE; Bauwens SF; Collins TM
    J Am Geriatr Soc; 1988 Jun; 36(6):531-6. PubMed ID: 3131410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Famotidine in gastroesophageal reflux disease (GERD).
    Wesdorp IC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical appropriateness, therapeutic equivalence, and cost of conversion of H2 antagonist therapy.
    Kitrenos JG; Brown DR; Letting DJ; Rotella DL
    Hosp Formul; 1993 Jan; 28(1):86-8, 91, 95-6. PubMed ID: 10123271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using multiple pharmacoeconomic methods to conduct a cost-effectiveness analysis of histamine H2-receptor antagonists.
    McCoy S; Blayney-Chandramouli J; Mutnick A
    Am J Health Syst Pharm; 1998 Dec; 55(24 Suppl 4):S8-12. PubMed ID: 9872687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill.
    More DG; Raper RF; Munro IA; Watson CJ; Boutagy JS; Shenfield GM
    Surgery; 1985 Feb; 97(2):215-24. PubMed ID: 3881838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of cimetidine, famotidine, ranitidine, and mylanta in postoperative stress ulcers.
    Stuart RC; Hehir D
    Gastroenterology; 1992 Mar; 102(3):1091. PubMed ID: 1599547
    [No Abstract]   [Full Text] [Related]  

  • 37. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
    Hahm KB; Kim WH; Lee SI; Kang JK; Park IS
    Scand J Gastroenterol; 1995 Mar; 30(3):265-71. PubMed ID: 7770717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial].
    Amouretti M; Ansenay M; Bader JP; Baillet J; Bel A; Belaïche J; Benzenou A; Bertrand G; Bonfils S; Boucekkine T
    Gastroenterol Clin Biol; 1985 Feb; 9(2):147-52. PubMed ID: 3884426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment.
    Hui WM; Lam SK; Lok AS; Ng MM; Lai CL
    Am J Med; 1992 Mar; 92(3):265-74. PubMed ID: 1546725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.